Photo of Shane Stecklein from YouTube
Jan 7, 2024, 18:02
Shane Stecklein: My breast cancer patient with leptomeningeal metastasis is being denied life-prolonging therapy for her terminal cancer
Shane Stecklein, Breast, Hematology, Radiation Oncology and Cancer Biologist at KU Cancer Center, made the following post on X/Twitter:
”Shame on you Blue Cross and Blue Shield of Kansas (BCBSKS) for denying proton CSI for my breast cancer patient with leptomeningeal metastasis.
Phase II randomized trial of 63 patients showed ~2X median OS vs. WBRT. She paid premiums for DECADES and is now being denied life-prolonging therapy for her terminal cancer.”
Source: Shane Stecklein/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 18:02
Dec 22, 2024, 17:54
Dec 22, 2024, 17:51
Dec 22, 2024, 17:47
Dec 22, 2024, 17:44
Dec 22, 2024, 17:39
Dec 22, 2024, 17:36
Dec 22, 2024, 17:32
Dec 22, 2024, 17:18